293 related articles for article (PubMed ID: 28783148)
1. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
Ogata M; Oshima K; Ikebe T; Takano K; Kanamori H; Kondo T; Ueda Y; Mori T; Hashimoto H; Ogawa H; Eto T; Ueki T; Miyamoto T; Ichinohe T; Atsuta Y; Fukuda T
Bone Marrow Transplant; 2017 Nov; 52(11):1563-1570. PubMed ID: 28783148
[TBL] [Abstract][Full Text] [Related]
2. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
3. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
Ongrádi J; Ablashi DV; Yoshikawa T; Stercz B; Ogata M
J Neurovirol; 2017 Feb; 23(1):1-19. PubMed ID: 27538995
[TBL] [Abstract][Full Text] [Related]
4. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
[TBL] [Abstract][Full Text] [Related]
5. Retrospective case analysis of antiviral therapies for HHV-6 encephalitis after hematopoietic stem cell transplantation.
Toomey D; Phan TL; Nguyen V; Phan TT; Ogata M
Transpl Infect Dis; 2021 Feb; 23(1):e13443. PubMed ID: 32786154
[TBL] [Abstract][Full Text] [Related]
6. HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis?
Cheng FW; Lee V; Leung WK; Chan PK; Leung TF; Shing MK; Li CK
Pediatr Transplant; 2010 Jun; 14(4):483-7. PubMed ID: 19843234
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
[TBL] [Abstract][Full Text] [Related]
8. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
Ogata M; Takano K; Moriuchi Y; Kondo T; Ueki T; Nakano N; Mori T; Uoshima N; Nagafuji K; Yamasaki S; Shibasaki Y; Sakai R; Kato K; Choi I; Jo Y; Eto T; Kako S; Oshima K; Fukuda T
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1264-1273. PubMed ID: 29454651
[TBL] [Abstract][Full Text] [Related]
9. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
Ogata M
Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
[TBL] [Abstract][Full Text] [Related]
10. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
[TBL] [Abstract][Full Text] [Related]
13. Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act.
Zerr DM
J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S75-S78. PubMed ID: 30590622
[TBL] [Abstract][Full Text] [Related]
14. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.
Ogata M; Satou T; Kawano R; Goto K; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota JI
Bone Marrow Transplant; 2008 Feb; 41(3):279-85. PubMed ID: 18037945
[TBL] [Abstract][Full Text] [Related]
15. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
Pöhlmann C; Schetelig J; Reuner U; Bornhäuser M; Illmer T; Kiani A; Ehninger G; Jacobs E; Rohayem J
Clin Infect Dis; 2007 Jun; 44(12):e118-20. PubMed ID: 17516391
[TBL] [Abstract][Full Text] [Related]
16. [Human herpesvirus 6 encephalitis].
Yoshikawa T
Brain Nerve; 2010 Aug; 62(8):869-75. PubMed ID: 20714035
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir-resistant HHV-6 encephalitis that progressed rapidly after bone marrow transplantation.
Imataki O; Uemura M
J Clin Virol; 2015 Aug; 69():176-8. PubMed ID: 26209402
[No Abstract] [Full Text] [Related]
19. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.
Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation.
Sakai R; Kanamori H; Motohashi K; Yamamoto W; Matsuura S; Fujita A; Ohshima R; Kuwabara H; Tanaka M; Fujita H; Maruta A; Ishigatsubo Y; Fujisawa S
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1389-94. PubMed ID: 21296175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
